The parent company of radiopharmaceutical firm Covidien has set in motion plans to incorporate in Ireland and relocate its executive office from Hamilton, Bermuda.
The company noted that one of the reasons for its decision is that Ireland is geographically beneficial for Covidien's growing presence in Europe, Africa, and Asia.
In a prepared statement, Covidien explained that its "reorganization will offer increased strategic flexibility and operational benefits as we continue to expand the rapidly growing international portion of our business."
Covidien has seven facilities, including five manufacturing, sales, and customer service operations in Ireland, as well as approximately 2,000 employees.
Covidien's Bermuda roots date back to its days as a wholly owned subsidiary of Tyco International. The company added that the decision to incorporate in Ireland will have no effect on its U.S. operations. The firm's Imaging Solutions business is based in Hazelwood, MO.
Related Reading
Covidien shows gains in fiscal 2008, November 17, 2008
PETNet, Covidien join forces, November 3, 2008
Road to RSNA, MRI, Covidien, October 31, 2008
Road to RSNA, CT, Covidien, October 29, 2008
Covidien gets FDA warning letter, September 25, 2008
Copyright © 2009 AuntMinnie.com
![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
